INTS: Intensity Therapeutics Inc

FinancialsDividends

$0.34

0.00

(0.60%)

As of 07/14/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

INTS Performance Snapshot

1-Week Chg

18.37%

1-Month Chg

5.35%

3-Month Chg

-82.09%

6-Month Chg

-87.12%

1-Year Chg

-93.42%

Year-To-Date Chg

-80.86%

Beta 1-Year

-0.37

Beta 5-Year

-0.06

Volatility (10-Day)

5.24%

INTS Technical Snapshot

Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-07-14

$0.34

$0.00 (0.6%)

$0.33

$0.37

$0.32

$0.34

6.55M ($2.19M)

2025-07-11

$0.33

$0.02 (5.38%)

$0.31

$0.34

$0.30

$0.33

7.77M ($2.59M)

2025-07-10

$0.32

$0.01 (2.27%)

$0.31

$0.33

$0.30

$0.32

5.29M ($1.67M)

2025-07-09

$0.31

$0.02 (6.55%)

$0.29

$0.32

$0.29

$0.31

12.31M ($3.80M)

2025-07-08

$0.29

$0.01 (2.47%)

$0.28

$0.31

$0.28

$0.29

3.74M ($1.08M)

2025-07-07

$0.28

-$0.01 (-4.07%)

$0.31

$0.31

$0.26

$0.28

3.61M ($1.02M)

2025-07-03

$0.29

-$0.01 (-1.67%)

$0.30

$0.32

$0.28

$0.30

1.23M ($363.74K)

2025-07-02

$0.30

-$0.01 (-2.6%)

$0.31

$0.31

$0.30

$0.30

501.00K ($150.30K)

2025-07-01

$0.31

$0.00 (0.33%)

$0.31

$0.31

$0.29

$0.30

768.00K ($236.54K)

2025-06-30

$0.31

-$0.01 (-4.06%)

$0.31

$0.35

$0.30

$0.32

4.20M ($1.29M)

INTS Financial Snapshot

Balance Sheet

(USD)

2025 Q1

Y/Y CHANGE

  • Cash and equivalents

    $929.00K

    -87.54%

  • Total assets

    $3.06M

    -75.30%

  • Total liabilities

    $2.73M

    1.68%

  • Total investments

    $0

    -100.00%

  • Shareholders' equity

    $334.00K

    -96.56%

  • Book value per share

    $0.02

    -96.90%

Income Statement

(USD)

2025 Q1

Y/Y CHANGE

  • Revenue

    $0

    0%

  • Net income

    -$3.35M

    27.29%

  • Operating expense

    $3.39M

    -28.44%

  • Gross profit

    $0

    0%

  • EBITDA

    -$3.34M

    27.32%

  • Earnings per share

    -$0.22

    35.29%

Cash Flow

(USD)

2025 Q1

Y/Y CHANGE

  • Net change in cash

    -$1.66M

    -51.28%

  • Cash from operations

    -$1.99M

    54.44%

  • Cash from investing

    $0

    -100.00%

  • Cash from financing

    $328.00K

    4000.00%

  • Free cash flow

    -$1.99M

    54.44%

  • Free cash flow per share

    -$0.13

    58.81%

Metrics

(USD)

2025 Q1

Y/Y CHANGE

  • Market capitalization

    $29.91M

    -58.05%

  • Enterprise value

    $27.43M

    -56.38%

  • Shares outstanding

    15.18M

    10.73%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -

Dividends

(USD)

2025 Q1

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    0.63

    -85.84%

View Financial Statements